(Q44821061)

6 December 2017

Interaction between chronic amphetamine and neuroleptic treatments on oral behavior in rats (English)

1 reference

6 December 2017

A D Levy

1

1 reference

PubMed ID

3122254

6 December 2017

G D Ellison

series ordinal

2

1 reference

6 December 2017

1 January 1987

1 reference

6 December 2017

1 reference

6 December 2017

93

1 reference

6 December 2017

2

1 reference

6 December 2017

218-222

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00179937

6 December 2017

0 references

cites work

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

1 reference

12 December 2020

Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model

1 reference

12 December 2020

Drug holidays alter onset of oral movements in rats following chronic haloperidol

1 reference

12 December 2020

Induction of oral dyskinesias in naive rats by D1 stimulation

1 reference

12 December 2020

Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration

1 reference

12 December 2020

Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.

1 reference

12 December 2020

Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.

1 reference

12 December 2020

Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats

1 reference

12 December 2020

Acute dystonia induced by neuroleptic drugs

1 reference

12 December 2020

Continuous amphetamine intoxication: an animal model of the acute psychotic episode.

1 reference

12 December 2020

The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia?

1 reference

12 December 2020

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

12 December 2020

A silicone pellet for longterm continuous administration of amphetamine

1 reference

12 December 2020

Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment

1 reference

12 December 2020

Opposite effects of a D1 and a D2 agonist on oral movements in rats

1 reference

12 December 2020

Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine

1 reference

12 December 2020

Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity

1 reference

12 December 2020

Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat

1 reference

12 December 2020

Tremorous mouth movements in rats administered chronic neuroleptics

1 reference

12 December 2020

Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitro

1 reference

12 December 2020

Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine Administration

1 reference

12 December 2020

Stages of constant amphetamine intoxication: Delayed appearance of abnormal social behaviors in rat colonies

1 reference

12 December 2020

Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.

1 reference

12 December 2020

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00179937

1 reference

6 December 2017

1 reference

PubMed ID

3122254